Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 1815123

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 1815123

Coccidiosis Vaccine for Chicken Market Report: Trends, Forecast and Competitive Analysis to 2031

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3850
PDF (2 Users License)
USD 4650
PDF (5 Users License)
USD 5350
PDF (Corporate License)
USD 7050

Add to Cart

The future of the global coccidiosis vaccine for chicken market looks promising with opportunities in the veterinary pharmacy and online sale markets. The global coccidiosis vaccine for chicken market is expected to grow with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are the rising poultry demand and the vaccine advancements & coccidiosis concerns fuel expansion.

  • Lucintel forecasts that, within the type category, trivalent vaccine is expected to witness higher growth over the forecast period due to rising demand for broad-spectrum protection against multiple eimeria species.
  • Within the application category, veterinary pharmacy is expected to witness the higher growth due to increasing availability and accessibility of poultry vaccines through veterinary pharmacies.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Coccidiosis Vaccine for Chicken Market

The global coccidiosis vaccine for chicken market is evolving with the advent of new technologies, growing awareness of poultry health, and a shift toward sustainable farming practices. These trends are reshaping how vaccines are developed, administered, and used across the world.

  • Shift Towards Reduced Antibiotic Use: As the poultry industry faces increasing pressure to reduce antibiotic use, vaccines for coccidiosis are gaining importance. Farmers are turning to vaccines to control the disease without resorting to antibiotics, aligning with global trends in reducing antimicrobial resistance.
  • Development of Recombinant and DNA-Based Vaccines: Research into recombinant vaccines and DNA-based technologies is leading to more effective solutions for coccidiosis. These vaccines provide better immunity and can be tailored to target specific strains of Eimeria, offering more precise protection and fewer side effects.
  • Integrated Vaccine Delivery Systems: The growing trend of integrating coccidiosis vaccines into automated poultry management systems makes it easier for large-scale poultry farms to administer vaccines consistently. These systems can manage vaccine delivery at a scale that reduces labor costs and ensures efficient and timely vaccination.
  • Increasing Regulatory Support: Governments and regulatory bodies across various countries are providing greater support for the development of effective coccidiosis vaccines. Strong regulatory frameworks ensure that vaccines meet safety standards, boosting consumer confidence and accelerating adoption within the poultry industry.
  • Rising Awareness of Animal Welfare: Growing concerns over animal welfare are driving demand for coccidiosis vaccines. With consumers increasingly concerned about the humane treatment of animals, the poultry industry is adopting vaccines as a means to reduce disease and suffering in chickens, aligning with the broader trend toward ethical farming practices.

These trends are reshaping the landscape of the coccidiosis vaccine for chicken market by increasing demand for innovative solutions that promote sustainability, efficiency, and animal welfare.

Recent Developments in the Coccidiosis Vaccine for Chicken Market

Recent developments in the global coccidiosis vaccine for chicken market reflect advancements in vaccine formulations, delivery methods, and regulatory standards. Key players are focusing on improving vaccine efficacy, reducing environmental impact, and addressing the growing concern over antibiotic resistance in poultry farming. These developments are shaping the future of the market by ensuring that vaccines are not only effective but also sustainable and aligned with global agricultural trends.

  • Recombinant Vaccine Development: Advances in recombinant vaccine technology have led to the development of more targeted and effective vaccines for coccidiosis. These vaccines offer better protection against multiple strains of Eimeria, reduce the risk of side effects, and provide enhanced immunity, making them increasingly popular in large-scale poultry operations.
  • Improved Delivery Systems: New vaccine delivery systems, including oral and water-based vaccines, are simplifying the vaccination process, particularly in large poultry farms. These systems ensure consistent and efficient vaccine administration, reducing labor costs and ensuring better disease control.
  • Focus on Antibiotic-Free Poultry Farming: With a growing demand for antibiotic-free poultry products, vaccines have become a crucial tool in controlling coccidiosis. The shift toward antibiotic-free farming is driving the market for coccidiosis vaccines, as they help reduce the need for antibiotics and support sustainable farming practices.
  • Enhanced Vaccine Safety and Efficacy: There is a continuous push to improve the safety and efficacy of coccidiosis vaccines. This includes minimizing adverse reactions and ensuring that vaccines provide long-lasting immunity. These improvements are making vaccines a more attractive option for poultry farmers looking for reliable and effective disease management solutions.
  • Regulatory Advancements: Regulatory bodies in key markets such as the U.S. and Europe are tightening vaccine approval processes to ensure higher standards of safety and efficacy. These advancements in regulatory frameworks are accelerating the development and adoption of more advanced and reliable vaccines in the global market.

These developments are fostering a more robust and sustainable market for coccidiosis vaccines, driving increased adoption across various regions and poultry farming operations.

Strategic Growth Opportunities in the Coccidiosis Vaccine for Chicken Market

As the global coccidiosis vaccine for chicken market evolves, several growth opportunities are emerging, particularly in relation to new applications and technologies. These opportunities are fueled by demand for more efficient and sustainable poultry farming practices.

  • Growth in Emerging Markets: Developing countries, particularly in Asia and Africa, represent significant growth opportunities for coccidiosis vaccine producers. These regions are experiencing rapid growth in poultry production, and as the demand for healthier, more sustainable poultry farming practices rises, vaccines will become a critical tool in disease prevention.
  • Shift Toward Sustainable Farming Practices: As consumers demand more sustainably produced poultry, there is an increasing focus on vaccine-based disease control rather than antibiotics. This presents a growth opportunity for vaccine developers to offer solutions that meet the needs of environmentally conscious poultry producers.
  • Technological Integration in Poultry Farms: The integration of automated systems for vaccine administration presents a significant opportunity. As large-scale poultry farms adopt these technologies, there is growing demand for vaccines that can be easily integrated into automated health management systems, streamlining the vaccination process and improving overall farm efficiency.
  • Vaccine Innovations for Multistrain Protection: The growing complexity of coccidiosis strains presents a need for multistrain vaccines. Researchers are focused on developing vaccines that can target multiple strains of Eimeria, thus offering broader protection and reducing the need for repeated vaccinations, which will boost long-term vaccine adoption.
  • Regulatory Compliance and Global Expansion: As regulatory standards evolve, vaccine developers have the opportunity to expand into new markets by meeting increasingly stringent approval requirements. Companies that can navigate complex regulatory environments and offer vaccines that meet international standards will be well-positioned for growth in both developed and emerging markets.

These opportunities are transforming the global coccidiosis vaccine for chicken market by opening new avenues for growth and innovation.

Coccidiosis Vaccine for Chicken Market Driver and Challenges

The coccidiosis vaccine for chicken market is influenced by several drivers and challenges that shape the overall landscape. Technological advancements, increasing demand for antibiotic-free poultry, and stricter regulatory standards are among the major drivers, while challenges related to cost, production complexity, and market access remain significant.

The factors responsible for driving the coccidiosis vaccine for chicken market include:

1. Growing Demand for Antibiotic-Free Poultry: The rise in consumer demand for antibiotic-free poultry products is driving the adoption of coccidiosis vaccines. These vaccines offer an effective means of controlling the disease without relying on antibiotics, which aligns with growing public concerns over antimicrobial resistance.

2. Technological Advancements in Vaccine Development: The development of more effective and precise vaccines, such as recombinant and multistrain vaccines, is pushing the market forward. These innovations provide better protection and efficiency, reducing the risk of coccidiosis outbreaks and enhancing poultry productivity.

3. Regulatory Support and Policy Changes: Governments are increasingly implementing stricter regulations and offering support for the development of coccidiosis vaccines. These regulatory changes help ensure that vaccines meet safety and efficacy standards, fostering market growth and encouraging adoption in both developed and emerging markets.

4. Rising Awareness of Animal Welfare: With growing concerns about animal welfare, there is a shift toward more humane poultry farming practices. Vaccines provide an ethical alternative to disease control, ensuring healthier and more humane conditions for chickens, which further drives demand for vaccines.

5. Expanding Poultry Production in Emerging Markets: Rapid growth in poultry farming, particularly in emerging markets, is creating demand for effective disease control solutions. As these markets expand, coccidiosis vaccines are becoming essential for maintaining healthy poultry populations and ensuring high-quality meat production.

Challenges in the coccidiosis vaccine for chicken market are:

1. High Production and Development Costs: The development and production of advanced coccidiosis vaccines can be expensive, limiting access to smaller producers in emerging markets. High costs may also slow the rate of adoption of new vaccine technologies in certain regions.

2. Vaccine Delivery and Administration Complexity: Ensuring that vaccines are delivered consistently and efficiently in large-scale poultry operations can be challenging. The complexity of administering vaccines to large numbers of chickens, particularly in remote areas, can hinder market growth.

3. Market Access and Regulatory Hurdles: While regulatory advancements are helping the market, navigating complex regulatory frameworks in different countries remains a challenge for vaccine manufacturers. This can delay market entry and limit the ability to expand into new regions.

These drivers and challenges are shaping the global coccidiosis vaccine for chicken market by influencing the development, distribution, and adoption of vaccines across regions.

List of Coccidiosis Vaccine for Chicken Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies coccidiosis vaccine for chicken companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the coccidiosis vaccine for chicken companies profiled in this report include-

  • Ceva
  • Zoetis
  • Elanco
  • Merck & Co
  • Virbac

Coccidiosis Vaccine for Chicken Market by Segment

The study includes a forecast for the global coccidiosis vaccine for chicken market by type, application, and region.

Coccidiosis Vaccine for Chicken Market by Type [Value from 2019 to 2031]:

  • Trivalent Vaccine
  • Quadrivalent Vaccine

Coccidiosis Vaccine for Chicken Market by Application [Value from 2019 to 2031]:

  • Veterinary Pharmacy
  • Online Sale
  • Others

Coccidiosis Vaccine for Chicken Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Coccidiosis Vaccine for Chicken Market

The global coccidiosis vaccine for chicken market has experienced significant developments driven by technological advancements, increasing poultry farming practices, and a growing need for sustainable solutions. With regions like the U.S., China, Germany, India, and Japan leading in vaccine adoption and research, new formulations and improved vaccine efficacy are shaping the future of poultry health management. These advancements are helping mitigate the impact of coccidiosis, a major poultry disease.

  • United States: The U.S. market for coccidiosis vaccines is expanding with increased research into recombinant vaccines and new delivery methods. Companies are focusing on enhancing vaccine efficacy and safety, particularly against emerging strains of Eimeria. Innovations in vaccine formulations that allow for broader immunity and reduced environmental impact are gaining traction in the U.S. poultry industry.
  • China: China's coccidiosis vaccine for chicken market is growing rapidly due to its massive poultry production sector. The Chinese government has intensified its efforts in poultry disease control, including coccidiosis. Domestic vaccine production has seen significant improvements, with companies focusing on more effective vaccines that reduce dependence on antibiotics and improve overall chicken health and productivity in commercial farms.
  • Germany: In Germany, advancements in molecular biology and vaccine development are helping improve the efficiency and safety of coccidiosis vaccines. Research focuses on improving immune responses and reducing vaccine-related side effects. The German market also emphasizes regulatory compliance, with strong support from agricultural and veterinary authorities, contributing to a high standard of poultry health and vaccination practices.
  • India: India's coccidiosis vaccine for chicken market is growing as the poultry industry expands to meet increasing consumer demand. New vaccine formulations, including live attenuated vaccines, are becoming popular in India for their efficacy in preventing coccidiosis in large-scale commercial farms. Additionally, the government is promoting better poultry health management practices, encouraging the adoption of vaccines as a preventive measure against the disease.
  • Japan: Japan's coccidiosis vaccine for chicken market is focusing on the development of vaccines with reduced environmental impact and increased vaccine effectiveness. Research in Japan is directed at integrating vaccine administration into automated poultry management systems, offering ease of use in large-scale poultry operations. The government's regulatory focus ensures that only the safest, most effective vaccines are used, supporting sustainable poultry farming practices.

Features of the Global Coccidiosis Vaccine for Chicken Market

  • Market Size Estimates: Coccidiosis vaccine for chicken market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Coccidiosis vaccine for chicken market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Coccidiosis vaccine for chicken market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the coccidiosis vaccine for chicken market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the coccidiosis vaccine for chicken market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the coccidiosis vaccine for chicken market by type (trivalent vaccine and quadrivalent vaccine), application (veterinary pharmacy, online sale, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Coccidiosis Vaccine for Chicken Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Trivalent Vaccine: Trends and Forecast (2019-2031)
  • 4.4 Quadrivalent Vaccine: Trends and Forecast (2019-2031)

5. Global Coccidiosis Vaccine for Chicken Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Veterinary Pharmacy: Trends and Forecast (2019-2031)
  • 5.4 Online Sale: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Coccidiosis Vaccine for Chicken Market by Region

7. North American Coccidiosis Vaccine for Chicken Market

  • 7.1 Overview
  • 7.2 North American Coccidiosis Vaccine for Chicken Market by Type
  • 7.3 North American Coccidiosis Vaccine for Chicken Market by Application
  • 7.4 United States Coccidiosis Vaccine for Chicken Market
  • 7.5 Mexican Coccidiosis Vaccine for Chicken Market
  • 7.6 Canadian Coccidiosis Vaccine for Chicken Market

8. European Coccidiosis Vaccine for Chicken Market

  • 8.1 Overview
  • 8.2 European Coccidiosis Vaccine for Chicken Market by Type
  • 8.3 European Coccidiosis Vaccine for Chicken Market by Application
  • 8.4 German Coccidiosis Vaccine for Chicken Market
  • 8.5 French Coccidiosis Vaccine for Chicken Market
  • 8.6 Spanish Coccidiosis Vaccine for Chicken Market
  • 8.7 Italian Coccidiosis Vaccine for Chicken Market
  • 8.8 United Kingdom Coccidiosis Vaccine for Chicken Market

9. APAC Coccidiosis Vaccine for Chicken Market

  • 9.1 Overview
  • 9.2 APAC Coccidiosis Vaccine for Chicken Market by Type
  • 9.3 APAC Coccidiosis Vaccine for Chicken Market by Application
  • 9.4 Japanese Coccidiosis Vaccine for Chicken Market
  • 9.5 Indian Coccidiosis Vaccine for Chicken Market
  • 9.6 Chinese Coccidiosis Vaccine for Chicken Market
  • 9.7 South Korean Coccidiosis Vaccine for Chicken Market
  • 9.8 Indonesian Coccidiosis Vaccine for Chicken Market

10. ROW Coccidiosis Vaccine for Chicken Market

  • 10.1 Overview
  • 10.2 ROW Coccidiosis Vaccine for Chicken Market by Type
  • 10.3 ROW Coccidiosis Vaccine for Chicken Market by Application
  • 10.4 Middle Eastern Coccidiosis Vaccine for Chicken Market
  • 10.5 South American Coccidiosis Vaccine for Chicken Market
  • 10.6 African Coccidiosis Vaccine for Chicken Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Coccidiosis Vaccine for Chicken Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Ceva
    • Company Overview
    • Coccidiosis Vaccine for Chicken Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Zoetis
    • Company Overview
    • Coccidiosis Vaccine for Chicken Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Elanco
    • Company Overview
    • Coccidiosis Vaccine for Chicken Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Merck & Co
    • Company Overview
    • Coccidiosis Vaccine for Chicken Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Virbac
    • Company Overview
    • Coccidiosis Vaccine for Chicken Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Coccidiosis Vaccine for Chicken Market
  • Figure 2.1: Usage of Coccidiosis Vaccine for Chicken Market
  • Figure 2.2: Classification of the Global Coccidiosis Vaccine for Chicken Market
  • Figure 2.3: Supply Chain of the Global Coccidiosis Vaccine for Chicken Market
  • Figure 2.4: Driver and Challenges of the Coccidiosis Vaccine for Chicken Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Coccidiosis Vaccine for Chicken Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Coccidiosis Vaccine for Chicken Market ($B) by Type
  • Figure 4.3: Forecast for the Global Coccidiosis Vaccine for Chicken Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Trivalent Vaccine in the Global Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Quadrivalent Vaccine in the Global Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 5.1: Global Coccidiosis Vaccine for Chicken Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Coccidiosis Vaccine for Chicken Market ($B) by Application
  • Figure 5.3: Forecast for the Global Coccidiosis Vaccine for Chicken Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Veterinary Pharmacy in the Global Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Online Sale in the Global Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 6.1: Trends of the Global Coccidiosis Vaccine for Chicken Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Coccidiosis Vaccine for Chicken Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 7.2: North American Coccidiosis Vaccine for Chicken Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Coccidiosis Vaccine for Chicken Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Coccidiosis Vaccine for Chicken Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Coccidiosis Vaccine for Chicken Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Coccidiosis Vaccine for Chicken Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Coccidiosis Vaccine for Chicken Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 8.2: European Coccidiosis Vaccine for Chicken Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Coccidiosis Vaccine for Chicken Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Coccidiosis Vaccine for Chicken Market ($B) by Type (2025-2031)
  • Figure 8.5: European Coccidiosis Vaccine for Chicken Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Coccidiosis Vaccine for Chicken Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Coccidiosis Vaccine for Chicken Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 9.2: APAC Coccidiosis Vaccine for Chicken Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Coccidiosis Vaccine for Chicken Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Coccidiosis Vaccine for Chicken Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Coccidiosis Vaccine for Chicken Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Coccidiosis Vaccine for Chicken Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Coccidiosis Vaccine for Chicken Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Figure 10.2: ROW Coccidiosis Vaccine for Chicken Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Coccidiosis Vaccine for Chicken Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Coccidiosis Vaccine for Chicken Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Coccidiosis Vaccine for Chicken Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Coccidiosis Vaccine for Chicken Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Coccidiosis Vaccine for Chicken Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Coccidiosis Vaccine for Chicken Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Coccidiosis Vaccine for Chicken Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Coccidiosis Vaccine for Chicken Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Coccidiosis Vaccine for Chicken Market by Type
  • Figure 12.2: Growth Opportunities for the Global Coccidiosis Vaccine for Chicken Market by Application
  • Figure 12.3: Growth Opportunities for the Global Coccidiosis Vaccine for Chicken Market by Region
  • Figure 12.4: Emerging Trends in the Global Coccidiosis Vaccine for Chicken Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Coccidiosis Vaccine for Chicken Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Coccidiosis Vaccine for Chicken Market by Region
  • Table 1.3: Global Coccidiosis Vaccine for Chicken Market Parameters and Attributes
  • Table 3.1: Trends of the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 3.2: Forecast for the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Coccidiosis Vaccine for Chicken Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 4.4: Trends of Trivalent Vaccine in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 4.5: Forecast for Trivalent Vaccine in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 4.6: Trends of Quadrivalent Vaccine in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 4.7: Forecast for Quadrivalent Vaccine in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Coccidiosis Vaccine for Chicken Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 5.4: Trends of Veterinary Pharmacy in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 5.5: Forecast for Veterinary Pharmacy in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 5.6: Trends of Online Sale in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 5.7: Forecast for Online Sale in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 7.1: Trends of the North American Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 7.2: Forecast for the North American Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 8.1: Trends of the European Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 8.2: Forecast for the European Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 9.1: Trends of the APAC Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 9.2: Forecast for the APAC Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 10.1: Trends of the ROW Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 10.2: Forecast for the ROW Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Coccidiosis Vaccine for Chicken Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Coccidiosis Vaccine for Chicken Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Coccidiosis Vaccine for Chicken Market (2019-2031)
  • Table 11.1: Product Mapping of Coccidiosis Vaccine for Chicken Suppliers Based on Segments
  • Table 11.2: Operational Integration of Coccidiosis Vaccine for Chicken Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Coccidiosis Vaccine for Chicken Revenue
  • Table 12.1: New Product Launches by Major Coccidiosis Vaccine for Chicken Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Coccidiosis Vaccine for Chicken Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!